Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Niosomes improve minoxidil skin delivery for hair loss treatment.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Dermatologists need to understand hair products to treat hair and scalp issues better.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Minoxidil and finasteride effectively treat hair loss.

Removing both KLK5 and KLK7 proteins can prevent death and skin issues in Netherton syndrome.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Advanced human skin models improve drug development and could replace animal testing.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Skin problems are very common in people with end-stage kidney disease.

Dermoscopy improves diagnosis and treatment monitoring for children's skin infections, inflammations, and hair disorders.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

Nanoparticles can enter the skin, potentially causing toxicity, especially in damaged skin.

Nanocrystals improve skin penetration and stability of caffeine, suggesting a new method for delivering similar substances through the skin.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

High proliferation and cell delamination drive early skin development, while later stages may not rely on cell division orientation.